Osong Public Health and Research Perspectives

Original Articles

A Healthcare-Associated Outbreak of HCV Genotype 2a at a Clinic in Seoul: Siwon Choi, Hyerim Lee, Hyungmin Lee, Yoon-Seok Chung; Osong Public Health Res Perspect. 2021;12(1):3-12. Published online February 23, 2021; DOI: https://doi.org/10.24171/j.phrp.2021.12.1.02

6,190 View
255 Download

Abstract PDF: Objectives
An epidemiological investigation was conducted into a hepatitis C virus (HCV) outbreak at an outpatients clinic in Seoul (2011–2012). The aim of the study was to analyze the scale of infection, identify the source of infection, and route of transmission to prevent hepatitis C transmission in the future.
Methods
A retrospective study of the outpatients and health care workers (n = 7,285) in the target outpatient clinic during 2011–2012 was conducted. The history of the study population infection with hepatitis C, electronic medical records, field visits, and health care worker interviews were examined for the period between March 1^st, 2006 and March 25^th, 2016. The blood samples were collected and tested for anti-HCV antibodies, HCV RNA and HCV gene in 2016.
Results
The rate of anti-HCV positive results was 4.4% in the study population. The risk factors associated with an anti-HCV positive result were ≥ 10 clinic visits, and receiving an invasive procedure including a nerve block and a block of the peripheral branch of the spinal nerve (p < 0.05). There were 112 HCV RNA positive cases out of 320 anti-HCV positive test result cases, amongst which 100 cases had the dominant HCV genotype 2a which formed either 1 cluster (n = 56) or 2 clusters (n = 25). This result indicated exposure to a high-association infection source.
Conclusion
Anti-HCV antibodies and genotypic analysis showed an epidemiological association between the outbreak of HCV and invasive procedures performed (2011–2012) at an outpatients clinic in Seoul.

Treatment with Sofosbuvir and Daclatasvir (with or without Ribavirin) Improves Patient Reported Outcomes in Hepatitis C: Lucas Pereira Jorge de Medeiros, Mario Barreto Correa Lima, Marcia Maria Amêndola Pires, Alessandra Mendonça Almeida Maciel, Renata Barboza Vianna Medeiros, Mariana Dermínio Donadel, Isabela Martins Becattini Pereira, Fábio Marchon Leão, Luiz Eduardo Amorim Correa Lima Pires, Helio Rzetelna, Carlos Eduardo Brandão-Mello; Osong Public Health Res Perspect. 2018;9(2):50-58. Published online April 30, 2018; DOI: https://doi.org/10.24171/j.phrp.2018.9.2.03

5,723 View
42 Download
4 Crossref

Objectives

To evaluate the impact of 3 treatment regimens upon health-related quality of life and work productivity using patient-reported outcomes (PROs) in chronic hepatitis C infected patients: sofosbuvir (SOF) + daclatasvir (DCV); SOF + DCV + ribavirin (RBV); SOF + simeprevir (SMV).

Methods

4 questionnaires were used to evaluate PROs before, during and after treatment: Short Form-36 (SF-36), Chronic Liver Disease Questionnaire (CLDQ) - hepatitis C virus (HCV), Work Productivity and Activity Index, Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F).

Results

Of the global sample of 55 patients included in this study; SOF + DCV (n = 10); SOF + DCV + RBV (n = 29); SOF + SMV (n = 16) all had a statistically significant improvement in SF-36, CLDQ and FACIT-F scores during and post-treatment. No statistically significant differences in the PRO questionnaire values were observed between the distinct treatment regimens. The SOF and SMV patient groups presented higher mean PRO variations during and post-treatment, compared to the other groups: SF-36 functional capacity (16.1); SF-36 mental health (21.4); CLDQ activity (1.8); CLDQ emotional function (1.2); FACIT-F physical well-being (8.0); Total FACIT-F (21.6).

Conclusion

Treatment with SOF + DCV, with or without RBV, results in an improved PRO similar to treatment with SOF + SMV in chronic hepatitis C patients.

Citations

Citations to this article as recorded by

Health-related quality of life in people receiving opioid agonist treatment and treatment for hepatitis C virus infection
Olav Dalgard, Alain H. Litwin, Oren Shibolet, Jason Grebely, Ronald Nahass, Frederick L. Altice, Brian Conway, Edward J. Gane, Anne F. Luetkemeyer, Cheng-Yuan Peng, David Iser, Isaias Noel Gendrano, Michelle M. Kelly, Barbara A. Haber, Heather Platt, Amy
Journal of Addictive Diseases.2023; 41(3): 213. CrossRef
Impact of sofosbuvir and daclastavir on health-related quality of life in patients co-infected with hepatitis C and human immunodeficiency virus
Evy Yunihastuti, Fhadilla Amelia, Arini Ika Hapsari, Bramantya Wicaksana, Veritea Natali, Alvina Widhani, Andri Sanityoso Sulaiman, Teguh Harjono Karjadi
Health and Quality of Life Outcomes.2021;[Epub] CrossRef
Health-related quality of life and fatigue in patients with chronic hepatitis C with therapy with direct-acting antivirals agents interferon-free
Raíssa Neves Fagundes, Lincoln Eduardo Villela Vieira de Castro Ferreira, Fábio Heleno de Lima Pace, Yury E. Khudyakov
PLOS ONE.2020; 15(8): e0237005. CrossRef
Efficacy and safety of sofosbuvir-based pangenotypic direct-acting antiviral agents for chronic hepatitis C patients without genotype determination
Juan Li, Dong-Bo Wu, Wei Jiang, Xue-Bin Chen, Gui-Bao Xiao, Yong-Hong Wang, Meng-Lan Wang, Ya-Chao Tao, En-Qiang Chen
Medicine.2020; 99(43): e22726. CrossRef

Quality of Life of Chronic Hepatitis C Patients and Its Associated Factors: Hoo Jeung Cho, Euna Park; Osong Public Health Res Perspect. 2017;8(2):124-129. Published online April 30, 2017; DOI: https://doi.org/10.24171/j.phrp.2017.8.2.04

5,238 View
34 Download
9 Crossref

Abstract PDF

Objectives

This study aimed to investigate the factors affecting the health-related quality of life (HRQOL) of patients with chronic hepatitis C (CHC).

Methods

This study is based on a descriptive survey and involved 125 gastroenterology outpatients visiting a university hospital in South Korea as the participants. HRQOL was assessed using the Liver Disease Quality of Life 1.0, which consisted of Short Form-36 (SF-36) and the Liver Disease Targeted Scale. Data were collected from December 2015 to April 2016, which were then analyzed through multiple regression analysis.

Results

HRQOL had a statistically significant correlation with age, sex, educational level, living type, employment status, monthly income level, and comorbidity status. This study showed that age > 51 years, female sex, high educational level, living alone, unemployment status, low monthly income, and presence of comorbidity had negative effects on the HRQOL of patients with CHC (R² = 8.7%–34.6%).

Conclusion

Based on the result of this study, intervention for patients with CHC needs to be developed to enhance their HRQOL. The findings can serve as a useful reference for nursing personnel in the development of therapeutic plans to upgrade the care of CHC patients.

Citations

Citations to this article as recorded by

Factors Affecting Health-related Quality of Life in Patients with Chronic Viral Hepatitis in Kazakhstan
Tatyana Vasiliyevna Polukchi, Yelena Alekseevna Slavko
Journal of Nature and Science of Medicine.2024;[Epub] CrossRef
Clinical and individual factors of quality of life of chronic liver disease patients at University of Gondar comprehensive specialized hospital, Northwest Ethiopia 2022
Eliud Teshome, Workagegnehu Hailu, Aynishet Adane, Endalkachew Belayneh Melese, Dessie Abebaw Angaw, Gebrekidan Ewnetu Tarekegn
Medicine.2023; 102(45): e35425. CrossRef
Risk factors of severe hepatotoxicity among HIV-1 infected individuals initiated on highly active antiretroviral therapy in the Northwest Region of Cameroon
Lem Edith Abongwa, Anthony Kebira Nyamache, Fokunang Charles, Judith Torimiro, Nshom Emmanuel, Irénée Domkam, Mbu Eyongetah, Beriyuy Jude, Fung Holgar Mua, Sama Bella, Tankou Colman Tamboh, Erna Charlene Moungang, Victorine Ngum, Paul Okemo
BMC Gastroenterology.2022;[Epub] CrossRef
Cathepsin B and Plasma Kallikrein Are Reliable Biomarkers to Discriminate Clinically Significant Hepatic Fibrosis in Patients with Chronic Hepatitis-C Infection
Alexia de Cassia Oliveira Zanelatto, Gilmar de Souza Lacerda, Camila de Melo Accardo, Natalia Fonseca do Rosário, Andréa Alice da Silva, Guacyara Motta, Ivarne Luis dos Santos Tersariol, Analucia Rampazzo Xavier
Microorganisms.2022; 10(9): 1769. CrossRef
Impact of newer direct-acting antiviral drugs based on quality-adjusted life years
Bhavya H. Vyas, Nishita H. Darji, Devang A. Rana, Kaushal Y. Vyas, Supriya D. Malhotra
Perspectives in Clinical Research.2021; 12(2): 76. CrossRef
Exploring Perception of Chronic Hepatitis C: An Idiographic Case Study
Hana Arshad, Subha Malik
Pakistan Journal of Psychological Research.2020; 34(4): 735. CrossRef
Changes in Quality of Life of Chronic Hepatitis C Patients Participating in Clinical Trial
Hoo-Jeung CHO, Euna PARK
JOURNAL OF FISHRIES AND MARINE SCIENCES EDUCATION.2018; 30(5): 1725. CrossRef
Treatment with Sofosbuvir and Daclatasvir (with or without Ribavirin) Improves Patient Reported Outcomes in Hepatitis C
Lucas Pereira Jorge de Medeiros, Mario Barreto Correa Lima, Marcia Maria Amêndola Pires, Alessandra Mendonça Almeida Maciel, Renata Barboza Vianna Medeiros, Mariana Dermínio Donadel, Isabela Martins Becattini Pereira, Fábio Marchon Leão, Luiz Eduardo Amor
Osong Public Health and Research Perspectives.2018; 9(2): 50. CrossRef
Quality of life in Brazilian patients with treated or untreated chronic hepatitis C
Cássio Marques Perlin, Vinicius Lins Ferreira, Helena Hiemisch Lobo Borba, Astrid Wiens, Cláudia Alexandra Pontes Ivantes, Luana Lenzi, Roberto Pontarolo
Revista do Instituto de Medicina Tropical de São P.2017;[Epub] CrossRef

Illness Experience of Patients with Chronic Hepatitis C Participating in Clinical Trials: Hoo-Jeung Cho, Euna Park; Osong Public Health Res Perspect. 2016;7(6):394-399. Published online December 31, 2016; DOI: https://doi.org/10.1016/j.phrp.2016.11.001

3,699 View
23 Download
5 Crossref

Abstract PDF

Objectives
To understand the illness experience of patients with chronic hepatitis C participating in clinical trials in the sociocultural context of Korea in an in-depth and comprehensive manner.
Methods
A focused ethnography approach was used to discover the pattern of illness experience of patients with chronic hepatitis C in the cultural background of Korea. Interviews were conducted with 11 patients with chronic hepatitis C participating in clinical trials and the collected data were analyzed with the domain analysis, taxonomical analysis, componential analysis, and theme analysis proposed by Spradley.
Results
With the cultural theme of “less-known illness, less-familiar illness,” four categories were derived: “my illness discovered by accident,” “shaken life,” “scary but inevitable treatment method,” and “precious life that can't be wasted,” along with 12 properties.
Conclusion
Public campaigns or education programs are needed to meet the needs for information on the disease for patients with chronic hepatitis C participating in clinical trials and help the general public acquire knowledge or change view on this disease.

Citations

Citations to this article as recorded by

Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada
Gayatri Marathe, Erica E M Moodie, Marie-Josée Brouillette, Charlotte Lanièce Delaunay, Joseph Cox, Valérie Martel-Laferrière, John Gill, Curtis Cooper, Neora Pick, Marie-Louise Vachon, Sharon Walmsley, Marina B Klein, Lisa Barrett, Jeff Cohen, Brian Conw
Clinical Infectious Diseases.2023; 76(3): e702. CrossRef
“There are many fevers”: Communities’ perception and management of Febrile illness and its relationship with human animal interactions in South-Western Uganda
Michael Wandanje Mahero, Katherine M. Pelican, Jacinta M. Waila, Shamilah Namusisi, Innocent B. Rwego, Charles Kajura, Christopher Nyatuna, David R. Boulware, Joel Hartter, Lawrence Mugisha, Cheryl Robertson, Dominic A. Travis, Kate Zinszer
PLOS Neglected Tropical Diseases.2022; 16(2): e0010125. CrossRef
Effect of Disease-related Knowledge and Health Enhancement Lifestyle on Self-management Behavior among Chronic Hepatitis C Patients
Hoo Jeung CHO, Euna PARK
THE JOURNAL OF FISHERIES AND MARINE SCIENCES EDUCA.2022; 34(2): 219. CrossRef
Assessing potential cures: are there distinctive elements of value beyond health gain?
Saskia Hendriks, Steven D Pearson
Journal of Comparative Effectiveness Research.2021; 10(4): 255. CrossRef
Depression in patients with chronic hepatitis-C treated with direct-acting antivirals: A real-world prospective observational study
Mohamed A. Khalil, Hend Ibrahim Shousha, Saeed M. El-Nahaas, Mohamed Ibrahim Negm, Kariman Kamal, Nagwan Mohamed Madbouly
Journal of Affective Disorders.2021; 282: 126. CrossRef

Comparison of Three Different Methods for Detection of IL28 rs12979860 Polymorphisms as a Predictor of Treatment Outcome in Patients with Hepatitis C Virus: Abolfazl Fateh, Mohammadreza Aghasadeghi, Seyed D. Siadat, Farzam Vaziri, Farzin Sadeghi, Roohollah Fateh, Hossein Keyvani, Alireza H. Tasbiti, Shamsi Yari, Angila Ataei-Pirkooh, Seyed H. Monavari; Osong Public Health Res Perspect. 2016;7(2):83-89. Published online April 30, 2016; DOI: https://doi.org/10.1016/j.phrp.2015.11.004

3,446 View
22 Download
23 Crossref

Abstract PDF

Objectives
This study aimed to evaluate the specificity, sensitivity, cost, and turn-around time of three methods of gene polymorphism analysis and to study the relationship between IL28B rs12979860 and SVR rate to pegIFN-α/RVB therapy among patients with chronic hepatitis C.
Methods
A total of 100 samples from chronic hepatitis C patients were analyzed in parallel using the three methods: direct sequencing, real-time polymerase chain reaction (PCR), amplification refractory mutation system (ARMS)-PCR.
Results
The different profiles for IL28B rs12979860 alleles (CC, CT, and TT) obtained with PCR-RFLP, ARMS-PCR, and direct sequencing were consistent among the three methods. Prevalence of rs12979860 genotypes CC, CT and TT in HCV genotype 1a was 10(19.6%), 35(68.6%), and six (11.8%), respectively, and in HCV genotype 31, it was 13(26.5%), 31(63.3%), and five (10.2%), respectively. No significant difference was seen between rs12979860 genotype and HCV genotype (p = 0.710).
Conclusion
Screening by ARMS – PCR SNOP detection represents the most efficient and reliable method to determine HCV polymorphisms in routine clinical practice.

Citations

Citations to this article as recorded by

Multiplex Snapshot Minisequencing for the Detection of Common PAH Gene Mutations in Iranian Patients with Phenylketonuria
Pegah Namdar Aligoodarzi, Golale Rostami, Seyed Reza Kazemi Nezhad, Mohammad Hamid
Iranian Biomedical Journal.2023; 27(1): 46. CrossRef
Expression of TRIM56 Gene in SARS-CoV-2 Variants and its Relationship with Progression of COVID-19
Rezvan Tavakoli, Pooneh Rahimi, Mojtaba Hamidi-Fard, Sana Eybpoosh, Delaram Doroud, Iraj Ahmadi, Enayat Anvari, Mohammadreza Aghasadeghi, Abolfazl Fateh
Future Virology.2023; 18(9): 563. CrossRef
Performance of the tetra-primer PCR technique compared to PCR-RFLP in the search for rs12979860 (C/T) and rs8099917 (T/G) single nucleotide polymorphisms (SNPs) in the IFNL4 gene
Ellen Hochleitner Souza Kindermann, Karoline Rodrigues Campos, Adele Caterino-de-Araujo
Revista do Instituto Adolfo Lutz.2023; 82: 1. CrossRef
Glioblastoma as a Novel Drug Repositioning Target: Updated State
Hamed Hosseinalizadeh, Ammar Ebrahimi, Ahmad Tavakoli, Seyed Hamidreza Monavari
Anti-Cancer Agents in Medicinal Chemistry.2023; 23(11): 1253. CrossRef
Prevalence of Human Cytomegalovirus Infection in Iranian Prostate Cancer Patients
Ehsan Alborzi, Ahmad Tavakoli, Seyed Jalal Kiani, Saied Ghorbani, Davod Javanmard, Milad Sabaei, Maryam Fatemipour, Seyed Hamidreza Monavari
Iranian Journal of Medical Microbiology.2023; 17(4): 379. CrossRef
Performance of the tetra-primer PCR technique compared to PCR-RFLP in the search for rs12979860 (C/T) and rs8099917 (T/G) single nucleotide polymorphisms (SNPs) in the IFNL4 gene
Ellen Hochleitner Souza Kindermann, Karoline Rodrigues Campos, Adele Caterino-de-Araujo
Revista do Instituto Adolfo Lutz.2023; 82: 1. CrossRef
MicroRNAs Profiling in HIV, HCV, and HIV/HCV Co-Infected Patients
Mohsen Moghoofei, Sohrab Najafipour, Shayan Mostafaei , Ahmad Tavakoli , Farah Bokharaei-Salim , Saied Ghorbani, Davod Javanmard, Hadi Ghaffari , Seyed Hamidreza Monavari
Current HIV Research.2021; 19(1): 27. CrossRef
Occult hepatitis C virus infection in hemophilia patients and its correlation with interferon lambda 3 and 4 polymorphisms
Amir Hossein Nafari, Ahmad Ayadi, Zahra Noormohamadi, Fatemeh Sakhaee, Farzam Vaziri, Seyed Davar Siadat, Abolfazl Fateh
Infection, Genetics and Evolution.2020; 79: 104144. CrossRef
Polymerase Chain Reaction Assay Using the Restriction Fragment Length Polymorphism Technique in the Detection of Prosthetic Joint Infections: A Multi-Centered Study
Ataollah Moshirabadi, Mohammad Razi, Peyman Arasteh, Mohammad Mahdi Sarzaeem, Saman Ghaffari, Saied Aminiafshar, Kami Hosseinian Khosroshahy, Fatemeh Maryam Sheikholeslami
The Journal of Arthroplasty.2019; 34(2): 359. CrossRef
One-Step ARMS-PCR for the Detection of SNPs—Using the Example of the PADI4 Gene
Sabrina Ehnert, Caren Linnemann, Bianca Braun, Josephine Botsch, Karolin Leibiger, Philipp Hemmann, Andreas K. Nussler
Methods and Protocols.2019; 2(3): 63. CrossRef
Epstein–Barr Virus and Risk of Breast Cancer: A Systematic Review and Meta-Analysis
Mohammad Farahmand, Seyed Hamidreza Monavari, Zabihollah Shoja, Hadi Ghaffari, Mehdi Tavakoli, Ahmad Tavakoli
Future Oncology.2019; 15(24): 2873. CrossRef
Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography
Eyal Shteyer, Louis Shekhtman, Tal Zinger, Sheri Harari, Inna Gafanovich, Dana Wolf, Hefziba Ivgi, Rima Barsuk, Ilana Dery, Daniela Armoni, Mila Rivkin, Rahul Pipalia, Michal Cohen Eliav, Yizhak Skorochod, Gabriel S. Breuer, Ran Tur-kaspa, Yonit Weil Wien
PLOS ONE.2019; 14(1): e0210173. CrossRef
Correlation of CD81 and SCARB1 polymorphisms on virological responses in Iranian patients with chronic hepatitis C virus genotype 1
Milad Nafari, Shiva Irani, Farzam Vaziri, Safoora Gharibzadeh, Fatemeh Sakhaee, Mohammad Khazeni, Naser Kalhor, Fatemeh Rahimi Jamnani, Seyed Davar Siadat, Abolfazl Fateh
Infection, Genetics and Evolution.2018; 62: 296. CrossRef
First detection of human hepegivirus-1 (HHpgV-1) in Iranian patients with hemophilia
Yazdan Bijvand, Mohammad Reza Aghasadeghi, Fatemeh Sakhaee, Parviz Pakzad, Farzam Vaziri, Alireza Azizi Saraji, Fatemeh Rahimi Jamnani, Seyed Davar Siadat, Abolfazl Fateh
Scientific Reports.2018;[Epub] CrossRef
Evaluation of TRIM5 and TRIM22 polymorphisms on treatment responses in Iranian patients with chronic hepatitis C virus infection
Setareh Mobasheri, Nazanin Irani, Abbas Akhavan Sepahi, Fatemeh Sakhaee, Fatemeh Rahimi Jamnani, Farzam Vaziri, Seyed Davar Siadat, Abolfazl Fateh
Gene.2018; 676: 95. CrossRef
Data Mining and Machine Learning Algorithms Using IL28B Genotype and Biochemical Markers Best Predicted Advanced Liver Fibrosis in Chronic Hepatitis C
Hend Ibrahim Shousha, Abubakr Hussein Awad, Dalia Abdelhamid Omran, Mayada Mohamed Elnegouly, Mahasen Mabrouk
Japanese Journal of Infectious Diseases.2018; 71(1): 51. CrossRef
IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C
Parvaneh Sedighimehr, Shiva Irani, Fatemeh Sakhaee, Farzam Vaziri, Mohammadreza Aghasadeghi, Seyed Mehdi Sadat, Fatemeh Rahimi Jamnani, Abolfazl Fateh, Seyed Davar Siadat
Archives of Virology.2017; 162(1): 181. CrossRef
Comparison of Direct Sequencing, Real-Time PCR-High Resolution Melt (PCR-HRM) and PCR-Restriction Fragment Length Polymorphism (PCR-RFLP) Analysis for Genotyping of Common Thiopurine Intolerant Variant Alleles NUDT15 c.415C>T and TPMT c.719A>G (TPMT*3C)
Wai-Ying Fong, Chi-Chun Ho, Wing-Tat Poon
Diagnostics.2017; 7(2): 27. CrossRef
Effect of IL15 rs10833 and SCARB1 rs10846744 on virologic responses in chronic hepatitis C patients treated with pegylated interferon-α and ribavirin
Sahar Sadeghi, Mehdi Davari, Esmaeil Asli, Safoora Gharibzadeh, Farzam Vaziri, Fatemeh Rahimi Jamnani, Abolfazl Fateh, Seyed Davar Siadat
Gene.2017; 630: 28. CrossRef
High platelet count and high probability of CALR detection in myeloproliferative neoplasms
Reza Shirzad, Zari Tahan-nejad, Javad Mohamadi-asl, Mohammad Seghatoleslami, Ahmad Ahmadzadeh, Amal Saki Malehi, Najmaldin Saki
Comparative Clinical Pathology.2017; 26(1): 25. CrossRef
A comparative study of various methods for detection ofIL28Brs12979860 in chronic hepatitis C
Seyed Hamidreza Monavari, Roohollah Fateh, Farzam Vaziri, Fatemeh Rahimi Jamnani, Enayat Anvari, Farzin Sadeghi, Parviz Afrough, Ava Behrouzi, Fatemeh Sakhaee, Sepideh Meidaninikjeh, Hamidreza Mollaie, Alireza Hadizadeh Tasbiti, Shamsi Yari, Maryam Sadegh
Scandinavian Journal of Clinical and Laboratory In.2017; 77(4): 247. CrossRef
EGFR rs11506105 and IFNL3 SNPs but not rs8099917 are strongly associated with treatment responses in Iranian patients with chronic hepatitis C
M Asnavandi, M Zargar, F Vaziri, F R Jamnani, S Gharibzadeh, A Fateh, S D Siadat
Genes & Immunity.2017; 18(3): 144. CrossRef
Genetic Variation in Interleukin-28B and Response to Peg-IFNα-2a/RBV Combination Therapy in Patients with Hepatitis C Virus Infection
Farah Bokharaei-Salim, Mostafa Salehi-Vaziri, Farzin Sadeghi, Khadijeh Khanaliha, Maryam Esghaei, Seyed Hamidreza Monavari, Seyed Moayed Alavian, Shahin Fakhim, Hossein Keyvani
Jundishapur Journal of Microbiology.2016;[Epub] CrossRef

First
Prev
Page of 1
Next
Last

Search